Newsletter

The Biden-Harris administration has a new initiative called “Time Is Money.”

A rundown on some of the Democratic VP candidate’s important economic policy decisions.

A list of reasons why generative AI may be overhyped.

Novo Nordisk is powering Denmark’s economy with huge sales of Ozempic. But could its stratospheric growth pose a risk?

The Republican vice presidential candidate represents a sharp break from the Republicanism of yesteryear.

Companies have waged a quiet revolution in package sizing that they use to squeeze more money out of us. But there’s a weapon to help consumers level the playing field: unit prices.